Respostas Clínicas Cochrane
As Respostas Clínicas Cochrane (RCCs) proporcionam um ponto de entrada amigável, digerível e clinicamente focado para as pesquisas rigorosas das revisões sistemáticas Cochrane. Elas são desenvolvidas para serem acionáveis e para respaldar a tomada de decisão no local de atendimento, e foram adicionadas a seções relevantes do texto principal do Best Practice.
- How do alpha2-adrenergic agonists compare with placebo or methadone for management of opioid withdrawal?
- How does buprenorphine compare with methadone or adrenergic agonists in people undergoing opioid withdrawal?
- What are the effects of psychosocial treatments as an adjunct to pharmacological treatments in people undergoing opioid detoxification?
- What are the benefits and harms of buprenorphine maintenance versus placebo or methadone maintenance in people with opioid dependence?
- What are the benefits and harms of opioid agonist treatment for people who are dependent on pharmaceutical opioids?
- For individuals with opiate use disorders, what are the effects of dihydrocodeine for detoxification?
O uso deste conteúdo está sujeito ao nosso aviso legal